PatternsRadar
Sign in

PGHLProcter & Gamble Health Limited

NSE
5,589.50INR+53.00 (+0.96%)Close · 20 Nov 2026
2 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹9,278 CrMarket cap
24.4P/E (TTM)
58.1%Delivery

Filings & corporate actions

73 results filed
CSV
Next results · Q3 FY27
Expected 6 Feb 2027 – 12 Feb 2027
Estimate: filed 37–43 days after quarter end, last 5 times
Dividend
₹45.00 per share · last 27 Aug 2026
2026
  • 2 NovresultsResults · Q2 FY27 · standalone+0.5%NSE
  • 16 OctshareholdingShareholding · 30 Sept 2026+1.0%NSE
  • 27 AugdividendDividend · ₹45.00 per share-0.8%
  • 6 AugresultsResults · Q1 FY27 · standalone+1.3%NSE
  • 3 JulshareholdingShareholding · 30 Jun 2026-1.8%NSE
  • 27 MayresultsResults · Q4 FY26 · standalone-3.1%NSE
  • 26 MayresultsResults · Q4 FY26 · standalone+10.5%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026+1.3%NSE
  • 12 FebdividendDividend · ₹160.00 per share-5.7%
  • 6 FebresultsResults · Q3 FY26 · standalone+3.7%NSE
  • 21 JanshareholdingShareholding · 31 Dec 2025-0.7%NSE

Reaction to results · all yearsrose on day 0 in 40 of 76 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY272 Nov 2026+0.5%-2.2%—1.9×
Q1 FY276 Aug 2026+1.3%-2.2%-6.7%1.1×
Q4 FY2626 May 2026+10.5%+9.7%+10.3%29.2×
Q3 FY266 Feb 2026+3.7%-2.6%-5.7%3.5×
Q2 FY265 Nov 2025-1.1%-3.5%-3.5%2.9×
Q1 FY261 Aug 2025+1.1%+2.0%+1.6%2.3×
Q4 FY2517 Jun 2025+0.7%-0.1%-1.0%0.6×
Q3 FY2512 Feb 2025-1.1%-0.4%-4.0%2.9×
Q2 FY254 Nov 2024+4.9%+2.1%+5.9%28.6×
Q1 FY2522 Aug 2024-2.5%-3.1%-5.1%4.1×
Q4 FY243 May 2024-1.3%-2.2%-2.4%3.5×
Q3 FY247 Feb 2024+2.4%-4.8%-4.9%1.1×
Q2 FY244 Nov 2023-0.8%+1.2%-0.2%1.1×
Q1 FY2424 Aug 2023-4.8%-8.8%-9.0%5.2×
Q4 FY2316 May 2023+3.1%+7.6%+7.9%2.6×
Q3 FY236 Feb 2023+14.6%+14.3%+24.0%40.6×
Q2 FY2312 Nov 2022+3.2%+0.3%-1.0%2.8×
Q1 FY2330 Aug 2022+0.9%+3.2%-4.9%2.1×
Q4 FY226 May 2022-2.9%-2.4%-2.2%1.2×
Q3 FY229 Feb 2022-1.2%-7.2%-12.5%1.3×
Q2 FY229 Nov 2021-0.9%-5.8%-1.9%0.7×
Q1 FY2227 Aug 2021-0.9%-3.8%-2.7%1.1×
Q4 FY216 May 2021-6.6%-7.0%-7.2%8.2×
Q3 FY2111 Feb 2021+0.8%-3.7%-10.5%1.6×
Q2 FY2112 Nov 2020+5.4%+12.0%+24.2%4.4×
Q3 FY204 Mar 2020-0.7%-9.6%-3.9%1.3×
Q2 FY208 Nov 2019-6.4%-6.4%-8.4%3.6×
Q1 FY209 Aug 2019+0.2%-4.9%-7.1%1.3×
Q4 FY1910 May 2019+5.2%+22.5%+7.6%8.3×
Q3 FY197 Mar 2019-1.4%-2.5%+10.1%0.8×
Q2 FY199 Nov 2018-2.0%+0.3%-6.0%0.8×
Q1 FY1920 Aug 2018+4.7%+11.5%+5.3%0.5×
Q4 FY1818 Jun 2018+1.9%+4.3%-3.6%0.2×
Q3 FY1726 Feb 2018+0.6%+0.7%+0.8%0.5×
Q3 FY1826 Feb 2018+0.6%+0.7%+0.8%0.5×
Q2 FY1822 Nov 2017+0.1%-0.9%+9.2%1.8×
Q4 FY1712 Oct 2017+1.7%+14.1%+8.1%0.7×
Q1 FY182 Sept 2017+1.2%-4.0%-12.9%0.6×
Q2 FY1717 Nov 2016+4.6%+8.1%+20.2%2.5×
Q1 FY1721 Sept 2016+0.2%-4.2%+16.3%1.6×
Q3 FY1625 May 2016+0.2%+1.8%-1.7%0.4×
Q4 FY1616 May 2016+6.3%+3.1%+3.7%18.6×
Q2 FY1631 Oct 2015-2.2%-2.3%+0.3%1.8×
Q1 FY1616 Aug 2015-1.0%-7.8%-10.0%0.4×
Q4 FY159 May 2015+0.4%+1.1%-5.2%0.4×
Q3 FY156 Feb 2015-0.9%-2.1%+3.7%0.6×
Q2 FY1521 Nov 2014-1.4%-2.2%+2.0%0.7×
Q1 FY1519 Aug 2014-1.0%-3.9%+0.4%0.4×
Q4 FY145 May 2014-0.9%-3.2%-2.0%0.4×
Q3 FY141 Feb 2014-1.8%-2.6%+5.1%0.7×
Q2 FY1421 Oct 2013-2.2%-1.7%-1.5%0.9×
Q1 FY145 Aug 2013-0.8%+4.6%-2.7%0.3×
Q4 FY139 May 2013+1.3%+1.3%+2.3%1.4×
Q3 FY1328 Feb 2013-0.5%-0.8%-0.6%0.9×
Q2 FY131 Nov 20120.0%-1.4%+2.3%0.6×
Q1 FY1327 Jul 2012+1.0%+1.7%+1.2%2.0×
Q4 FY127 May 2012+0.4%-2.2%-6.5%0.1×
Q3 FY1229 Feb 2012-2.1%-3.9%-5.3%1.9×
Q2 FY121 Nov 2011-1.9%-0.4%-6.4%2.7×
Q1 FY1227 Jul 2011-1.3%-2.4%-10.7%0.4×
Q4 FY1125 Apr 2011-0.7%-6.8%-9.6%5.1×
Q2 FY1120 Oct 2010+20.0%+2.9%+0.3%79.0×
Q1 FY1129 Jul 2010+0.9%-0.1%-1.4%2.7×
Q4 FY1023 Apr 2010-0.8%-6.6%-5.3%1.1×
Q3 FY1022 Jan 2010-2.3%-4.3%-1.6%0.5×
Q2 FY1015 Oct 2009+17.1%+30.8%+33.9%42.0×
Q1 FY1020 Jul 2009+0.3%-0.2%+0.1%0.9×
Q4 FY0920 Apr 2009+1.0%-0.3%+12.7%7.5×
Q3 FY0927 Feb 2009-2.3%-4.0%+14.1%4.5×
Q2 FY0930 Oct 2008+0.8%+10.9%+0.6%0.5×
Q1 FY0930 Jul 2008+1.9%+4.4%+7.6%3.1×
Q4 FY0816 Apr 2008+0.7%+3.7%+6.5%1.5×
Q3 FY081 Feb 2008+1.4%-0.4%-0.5%1.0×
Q2 FY0818 Oct 2007————
Q1 FY0816 Jul 2007————
Q4 FY0720 Apr 2007————
Average+0.9%+0.4%+0.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+17.7%
Profit YoY+25.9%
Interest cost YoY+11.5%
Revenue QoQ+5.2%
Profit QoQ+16.0%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+13.4%+6.4%+7.0%+7.9%—+7.6%
Profit+32.1%+18.0%+17.3%+17.0%—-10.7%

Key data

Open5,537.00
Day range5,511.00 – 5,758.00
52-week range4,707.00 – 6,975.00
From 52w high-19.9%
RSI (14)51.7
ATR (14)202.11
Volume23.8K
Avg volume (20D)15.4K
Rel volume1.55×
Volatility (1Y)27.2%
Turnover₹13.4Cr
Traded value (NSE)₹13.4Cr
VWAP5,629.02
SMA 50 / 2005,442.62 / 5,595.88
Price band20%

Delivery percentage

Latest · 20 Nov 202658.1%
20-day avg51.8%
1-year avg59.0%
Percentile (own history)41st
Range10.6–99.0%
Sessions3,629

Over the last 20 sessions PGHL settled 51.8% of its traded quantity, which is above average for an NSE equity. Its one-year average is 59.0%, so recent sessions are running 7.2 points lower than usual. The latest session ranks higher than 41% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield3.67%
Dividend, trailing 12M₹205.00
Paid every year for6 yr
Shareholders50.4K · +2.8% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy4,694 days ago

Performance returns

1D1W1M3M6M1Y
Price+0.96%-3.78%+10.41%-4.17%+2.47%-5.10%

Valuation

Market cap₹9,278 Cr
Market cap (NSE)₹9,278 Cr
Free-float cap₹4,470 Cr
P/E (TTM)24.4
P/E (NSE)24.2
EPS (TTM)228.83
P/B14.1
Net margin (TTM)25.5%
Other income / PBT3.1%
ROE59.5%
Debt / equity0.00
Shares outstanding1.66Cr
Listed24 Apr 1996

Ownership

Promoter51.82%
Promoter Δ QoQ0.00 pp
Public48.18%
FII6.42%
DII12.63%
Pledged0.00%

Quarterly results · standalone

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)373.9370.5363.7382.5
YoY chg+20.7%+19.1%+7.4%+17.7%
Net profit (₹ Cr)77.694.696.2111.5
YoY chg-14.6%+54.6%+45.3%+25.9%
Net margin20.8%25.5%26.4%29.2%
EPS46.7456.9957.9267.18

Shareholding over time

By quarter

30 Sept 2026 · promoter 51.82% · public 48.18%
30 Sept 2021: promoter 51.82%31 Dec 2021: promoter 51.82%31 Mar 2022: promoter 51.82%30 Jun 2022: promoter 51.82%30 Sept 2022: promoter 51.85%31 Dec 2022: promoter 51.82%31 Mar 2023: promoter 51.82%30 Jun 2023: promoter 51.82%30 Sept 2023: promoter 51.82%31 Dec 2023: promoter 51.82%31 Mar 2024: promoter 51.82%30 Jun 2024: promoter 51.82%30 Sept 2024: promoter 51.82%31 Dec 2024: promoter 51.82%31 Mar 2025: promoter 51.82%30 Jun 2025: promoter 51.82%30 Sept 2025: promoter 51.82%31 Dec 2025: promoter 51.82%31 Mar 2026: promoter 51.82%30 Jun 2026: promoter 51.82%30 Sept 2026: promoter 51.82%
2021-092026-09
  • Promoter
  • Public and others
Promoter
51.82%
Public
48.18%
Promoter change
0.00 pp
Filed
16 Oct 2026
FII
6.42%
DII
12.63%
Promoter pledged
0.00%

Who the public is

Mutual funds
8.89%

-0.16 pp QoQ

Insurance
3.63%

+0.40 pp QoQ

FPI
6.43%

+0.10 pp QoQ

Retail ≤ ₹2L
21.54%

-0.06 pp QoQ

HNI > ₹2L
1.81%

-0.15 pp QoQ

NRI
2.42%

-0.09 pp QoQ

Bodies corporate
2.40%

+0.01 pp QoQ

Shareholders
50,426

+2.8% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
PROCTER AND GAMBLE OVERSEAS INDIA B.V.Promoter · Corporate51.82%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMAMutual fund4.18%
LIFE INSURANCE CORPORATION OF INDIAInsurance1.87%
UTI-MNC FUNDMutual fund1.45%
ADITYA BIRLA SUN LIFE MUTUAL FUND - ADITYA BIRLA SMutual fund1.22%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 7 Mar 2013 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹45.00₹45.00
FY2025-262₹205.00₹205.00
FY2024-252₹140.00₹140.00
FY2023-242₹250.00₹250.00
FY2022-233₹97.50₹97.50
FY2021-221₹130.00₹130.00
FY2020-211₹230.00₹230.00
FY2019-201₹440.00₹440.00
FY2018-191₹15.00₹15.00
FY2017-181₹11.00₹11.00
FY2016-171₹7.50₹7.50
FY2014-151₹6.00₹6.00
FY2013-141₹8.50₹8.50
FY2012-131₹2.50₹2.50
Ex-dateRecord dateDeclaredAdjusted
27 Aug 2026—₹45.00₹45.00
12 Feb 2026—₹160.00₹160.00
22 Aug 2025—₹45.00₹45.00
21 Feb 2025—₹80.00₹80.00
28 Nov 2024—₹60.00₹60.00
14 Feb 2024—₹200.00₹200.00
23 Nov 2023—₹50.00₹50.00
13 Feb 2023—₹45.00₹45.00
15 Nov 2022—₹11.50₹11.50
12 May 2022—₹41.00₹41.00
2 Nov 2021—₹130.00₹130.00
18 Nov 2020—₹230.00₹230.00
23 May 2019—₹440.00₹440.00
21 May 2018—₹15.00₹15.00
25 May 2017—₹11.00₹11.00
22 Apr 2016—₹7.50₹7.50
30 Mar 2015—₹6.00₹6.00
10 Mar 2014—₹8.50₹8.50
7 Mar 2013—₹2.50₹2.50

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
4
0 open-market of the newest 4
By year

No open-market insider trades among the recent disclosures.

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 3 Oct 2022

CSV
7 of 7 deals
By year
DateDealClientQuantityPriceValue
3 Oct 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO44.7K4,106.95₹18.4Cr
3 Oct 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF44.7K4,106.95₹18.4Cr
3 Oct 2022Sell · blockISHARES INDIA SC MAURITIUS COMPANY6.4K4,106.95₹2.6Cr
3 Oct 2022Buy · blockISHARES MSCI INDIA SMALL-CAP ETF6.4K4,106.95₹2.6Cr
13 Jan 2014Buy · bulkRELIANCE MUTUAL FUND A/C RELIANCE PHARMA FUND · as MERCK2.56L549.00₹14.1Cr
13 Jan 2014Sell · bulkAMERICAN FUND INSURANCE A/C AMERICAN INSURANCE SERIES GLOBAL · as MERCK1.42L549.00₹7.8Cr
13 Jan 2014Sell · bulkSMALLER CAP WORLD FUND INC · as MERCK1.14L549.00₹6.3Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to PGHL.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: band changes.

Every stock on this session →

Financials · quarterly statement

Standalone
₹ crore, as filed
By year
 Q3 FY24Q4 FY24Q1 FY25AQ2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations310.0252.5283.9313.4309.8311.0338.7324.9373.9370.5363.7382.5
Other income5.22.32.13.34.03.14.05.04.44.03.93.9
Total income315.2254.8286.0316.7313.7314.1342.8329.9378.2374.5367.6386.4
Total expenses215.4192.0243.0205.3192.0235.6254.0210.9269.4241.2270.3236.3
└ Finance costs0.20.20.20.20.20.10.10.10.10.20.10.1
└ Depreciation6.96.87.25.85.65.45.46.15.96.26.06.1
Profit before tax99.762.722.8111.4121.778.588.8119.0108.8133.2129.1150.1
Tax expense27.716.26.129.130.817.422.630.531.238.633.038.5
Net profit72.146.616.882.390.961.266.288.577.694.696.2111.5
EPS43.4028.0010.1149.6054.7636.8639.8753.3446.7456.9957.9267.18
Net margin23.25%18.44%5.91%26.27%29.34%19.67%19.54%27.25%20.75%25.54%26.44%29.15%
PBT margin32.17%24.84%8.04%35.54%39.28%25.25%26.22%36.63%29.11%35.96%35.50%39.23%
Tax rate27.73%25.77%26.50%26.10%25.30%22.09%25.48%25.61%28.70%28.98%25.53%25.68%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 2 Nov 2026.

Balance sheet & cash flow · half-yearly

Standalone
₹ crore, as filed
By year

Balance sheet

 Q1 FY24Q3 FY24Q1 FY25Q3 FY25FY25H1 FY26FY26H1 FY27
Total assets1,101.21,077.1794.4870.2794.2894.4841.41,014.6
Current assets796.1771.3515.2611.4526.4638.2556.3720.1
└ Cash & equivalents435.1420.6238.5266.4182.1279.3177.2322.9
└ Other bank balances5.25.05.96.36.56.98.16.2
└ Current investments0.00.00.00.00.00.00.00.0
└ Trade receivables115.7135.885.3130.7145.4137.5164.3175.8
└ Inventories134.9129.1109.1118.8109.4127.3136.7136.9
Total equity750.9805.9538.2610.5537.0619.7524.6658.1
└ Attributable to owners750.9805.9538.2610.5537.0619.7524.6658.1
└ Share capital16.616.616.616.616.616.616.616.6
Borrowings0.00.00.00.00.00.00.00.0
└ Current0.00.00.00.00.00.00.00.0
└ Non-current0.00.00.00.00.00.00.00.0
Trade payables237.0171.6167.0171.4171.6175.3192.2231.0
Current liabilities303.9230.5218.9219.9215.3222.5254.9296.9
Total liabilities350.3271.2256.1259.7257.2274.7316.8356.5
Net debt(440.2)(425.6)(244.4)(272.7)(188.6)(286.2)(185.3)(329.0)
Debt / equity0.000.000.000.000.000.000.000.00
Current ratio2.623.352.352.782.442.872.182.43

Cash flow, year to date

 Q1 FY24Q3 FY24Q1 FY25Q3 FY259M to FY25H1 FY26FY26H1 FY27
Operating cash flow236.074.6228.3119.5168.7172.2337.8190.9
└ Capex(42.5)(15.0)(21.7)(5.3)0.0(6.0)(15.5)(9.7)
Free cash flow193.559.6206.6114.1168.7166.2322.3181.2
Investing cash flow(21.5)(4.5)(6.9)9.69.61.41.331.7
Financing cash flow(98.5)(84.6)(418.1)(101.2)(234.7)(76.4)(343.9)(77.0)
└ Dividends paid(93.8)(83.0)(415.0)(99.6)(232.4)(74.7)(340.3)(74.7)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash116.0(14.5)(196.7)28.0(56.5)97.3(4.9)145.6

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

PGHL at a glance

  • PGHL closed at ₹5,589.5 on 20 Nov 2026, +0.96% on the day, -5.1% over one year, 19.9% below its 52-week high of ₹6,975.
  • Delivery was 58.1% of traded quantity on 20 Nov 2026, the 41st percentile of its own 3,629 sessions with a reading (20-session average 51.8%, 1-year average 59.0%).
  • Market capitalisation is ₹9,278 crore at a trailing P/E of 24.4 (trailing EPS ₹228.83).
  • Q2 FY27 results (standalone, filed 2 Nov 2026): revenue ₹382 crore (+17.7% year on year), net profit ₹112 crore (+25.9%); the price moved +0.5% on the first session after.
  • Promoters held 51.82% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 6 Feb 2027 and 12 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE199A01012
SeriesEQ
Listed24 Apr 1996
Former symbolsMERCK (until 11 Jun 2019), EMERCK (until 5 Nov 2007)
Former namesMerck Limited (until 11 Jun 2019)
NSE market cap · 17 Nov 2026₹9,071 Cr
Free-float market cap (NSE)₹4,337 Cr
Shares outstanding (NSE)1.66Cr
History from5 Nov 2007
Sessions4,714

Sector history

  1. to 5 Oct 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
  2. from 5 Oct 2026Index industry · Healthcare

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.